Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of neuroactive compounds and central nervous system modulators. Its structure supports the creation of selective receptor agonists or antagonists, making it valuable in drug discovery for neurological disorders such as epilepsy, depression, and neuropathic pain. The protected amine group allows for controlled chemical modifications, enabling precise derivatization in multi-step synthetic routes. Commonly employed in medicinal chemistry for building constrained cyclic amines that enhance metabolic stability and target selectivity in final drug candidates.